Pfizer / Weicai analgesic Lyrica (pregabalin) orally disintegrating tablet approved by Japan

Source: Sina Pharmaceutical News 2017-2-23 US pharmaceutical giant Pfizer and Japanese partner Eisai recently announced that the painkiller Lyrica (pregabalin) oral disintegrating tablets (OD tablets) 25mg, 75mg and 150mg were approved by Japanese regulatory authorities, which is a new dosage form of the painkiller Lyrica capsule In Japan, lycrica capsule is promoted by Pfizer and Weicai Lyrica od tablets can be rapidly disintegrating by saliva in the mouth, so the dosage form is very suitable for elderly patients One of the indications approved for Lyrica is neuropathic pain, which is caused by nerve compression or disorders caused by any disease Typical examples include: herpes zoster neuralgia, diabetic neuropathy pain, sciatica, and spinal cord injury pain Many of the patients with the above symptoms are elderly people, and lycrica od tablet is expected to provide convenience for such patients when taking medicine Through the launch of Lyrica od tablets, Pfizer and Weicai will continue to work to improve the quality of life of patients with neuropathic pain and fibromyalgia According to the published information, the dosage of Lyrica od tablet is: (1) neuropathic pain: Generally speaking, the initial oral dosage for adults is 150mg / day, twice a day; and gradually increases to 300mg / day after a week or several weeks; the dosage needs to be adjusted according to the age and symptoms of patients However, the maximum daily dose should not exceed 600 mg and should be taken twice daily (2) Fibromyalgia: Generally speaking, the initial oral dose for adults is 150mg / day, twice a day, and gradually increases to 300mg after a week or several weeks If necessary, it can be maintained at 300mg-450mg / day The dosage should be adjusted according to the patient's age and symptoms However, the maximum daily dose should not exceed 450 mg and should be given orally twice a day Original search: approximate received for panel treatment Lyca? Od table formulation in Japan